Billing and
Diagnosis Codes
The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.
Reimbursement and Coding Guide for ONUREG
Download
- Codes*
- Distribution
- FDA Letters
Note:Payers require the submission of the 11-digit NDC on healthcare claim forms. Please use the 11-digit codes shown here.
COPY
200-mg tablets; one blister card containing 7 tablets
COPY
200-mg tablets; one blister card containing 7 tablets
COPY
300-mg tablets; one blister card containing 7 tablets
COPY
300-mg tablets; one blister card containing 7 tablets
COPY
Myeloid leukemia†
COPY
Acute myeloblastic leukemia†
COPY
Acute myeloblastic leukemia, not having achieved remission
COPY
Acute myeloblastic leukemia, in remission
COPY
Acute myelomonocytic leukemia†
COPY
Acute myelomonocytic leukemia, not having achieved remission
COPY
Acute myelomonocytic leukemia, in remission
COPY
Acute myeloid leukemia with 11q23-abnormality†
COPY
Acute myeloid leukemia with 11q23-abnormality, not having achieved remission
COPY
Acute myeloid leukemia with 11q23-abnormality, in remission
COPY
Acute myeloid leukemia with multilineage dysplasia†
COPY
Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
COPY
Acute myeloid leukemia with multilineage dysplasia, in remission
COPY
Other myeloid leukemia†
COPY
Other myeloid leukemia, not having achieved remission
COPY
Other myeloid leukemia, in remission
COPY
Myeloid leukemia, unspecified†
COPY
Myeloid leukemia, unspecified, not having achieved remission
COPY
Myeloid leukemia, unspecified, in remission
COPY
Monocytic leukemia†
COPY
Acute monoblastic/monocytic leukemia†
COPY
Acute monoblastic/monocytic leukemia, not having achieved remission
COPY
Acute monoblastic/monocytic leukemia, in remission
COPY
Other leukemias of specified cell type†
COPY
Acute erythroid leukemia†
COPY
Acute erythroid leukemia, not having achieved remission
COPY
Acute erythroid leukemia, in remission
COPY
Acute megakaryoblastic leukemia†
COPY
Acute megakaryoblastic leukemia, not having achieved remission
COPY
Acute megakaryoblastic leukemia, in remission
The following distributors are authorized to sell ONUREG and are able to service qualified accounts.
Physician Offices
Specialty Distributor | Phone Orders | Fax Orders and Website |
---|---|---|
Cardinal Health Specialty Pharmaceutical Distribution | 1-877-453-3972 | https://specialtyonline.cardinalhealth.com |
CuraScript Specialty Distribution | 1-877-599-7748 | https://www.curascriptsd.com |
McKesson Specialty Health | 1-800-482-6700 | https://mscs.mckesson.com |
Oncology Supply | 1-800-633-7555 | https://www.oncologysupply.com |
Morris & Dickson Specialty | 1-800-710-6100 | Fax: 1-318-524-3096 https://www.mdspecialtydist.com |
Hospitals and Infusion Centers
Specialty Distributor | Phone Orders | Fax Orders and Website |
---|---|---|
ASD Healthcare | 1-800-746-6273 | Fax: 1-800-547-9413 https://www.asdhealthcare.com |
Cardinal Health Specialty Pharmaceutical Distribution | 1-866-677-4844 | Fax: 1-614-553-6301 https://orderexpress.cardinalhealth.com |
McKesson Plasma and Biologics | 1-877-625-2566 | Fax: 1-888-752-7626 https://connect.mckesson.com |
Morris & Dickson Specialty | 1-800-710-6100 | Fax: 1-318-524-3096 https://www.mdspecialtydist.com |
Puerto Rico Hospitals and Clinics
Authorized Distributor | Phone Orders | Fax Orders and Website |
---|---|---|
Cardinal Puerto Rico (Borschow) | 1-787-625-4200 | https://www.cardinalhealth.pr/ |
Cesar Castillo, Inc. | 1-787-641-5242 (Hospitals) 1-787-641-5082 (Specialty Pharmacies) |
Fax: 1-787-999-1614 https://www.facilfarmaciacci.com |
AmerisourceBergen Puerto Rico | 1-844-222-2273 | https://abcorder.amerisourcebergen.com |
Above information is accurate as of 03/22.
ONUREG is available through external specialty pharmacies. Please check with your patient’s insurance plan for the appropriate specialty pharmacy.
ONUREG can also be procured by the practice directly from one of the authorized distributors in the list above. Please ensure your practice has the durable medical equipment (DME) license in place to bill the appropriate DME Medicare Administrative Contractor (DME MAC).
Please see U.S. Full Prescribing Information for ONUREG.
FDA Approval Letter as Posted by the FDA:
ONUREG for the continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following intensive induction chemotherapy and are not able to complete intensive curative therapy - Approved on 09/01/2020
View Letter
Please see U.S. Full Prescribing Information for ONUREG.
The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.